Updated results of the FOENIX-CCA2 trial: Efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements
Goyal, L. Meric-Bernstam, F. Hollebecque, A. Morizane, C. Valle, Juan W Karasic, T. B. Abrams, T. A. Kelley, R. K. Cassier, P. A. Furuse, J.
Goyal, L.
Meric-Bernstam, F.
Hollebecque, A.
Morizane, C.
Valle, Juan W
Karasic, T. B.
Abrams, T. A.
Kelley, R. K.
Cassier, P. A.
Furuse, J.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Goyal L, Meric-Bernstam F, Hollebecque A, Morizane C, Valle JW, Karasic TB, et al. Updated results of the FOENIX-CCA2 trial: Efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680301177.